Correlation Between NRX Pharmaceuticals and Forte Biosciences
Can any of the company-specific risk be diversified away by investing in both NRX Pharmaceuticals and Forte Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRX Pharmaceuticals and Forte Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRX Pharmaceuticals and Forte Biosciences, you can compare the effects of market volatilities on NRX Pharmaceuticals and Forte Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRX Pharmaceuticals with a short position of Forte Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRX Pharmaceuticals and Forte Biosciences.
Diversification Opportunities for NRX Pharmaceuticals and Forte Biosciences
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NRX and Forte is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding NRX Pharmaceuticals and Forte Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Forte Biosciences and NRX Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRX Pharmaceuticals are associated (or correlated) with Forte Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Forte Biosciences has no effect on the direction of NRX Pharmaceuticals i.e., NRX Pharmaceuticals and Forte Biosciences go up and down completely randomly.
Pair Corralation between NRX Pharmaceuticals and Forte Biosciences
Given the investment horizon of 90 days NRX Pharmaceuticals is expected to under-perform the Forte Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, NRX Pharmaceuticals is 3.1 times less risky than Forte Biosciences. The stock trades about -0.16 of its potential returns per unit of risk. The Forte Biosciences is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 1,290 in Forte Biosciences on September 13, 2024 and sell it today you would earn a total of 1,078 from holding Forte Biosciences or generate 83.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NRX Pharmaceuticals vs. Forte Biosciences
Performance |
| Timeline |
| NRX Pharmaceuticals |
| Forte Biosciences |
NRX Pharmaceuticals and Forte Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NRX Pharmaceuticals and Forte Biosciences
The main advantage of trading using opposite NRX Pharmaceuticals and Forte Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRX Pharmaceuticals position performs unexpectedly, Forte Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forte Biosciences will offset losses from the drop in Forte Biosciences' long position.| NRX Pharmaceuticals vs. Biomx Inc | NRX Pharmaceuticals vs. Lexaria Bioscience Corp | NRX Pharmaceuticals vs. Aditxt Inc | NRX Pharmaceuticals vs. Nutriband |
| Forte Biosciences vs. Indaptus Therapeutics | Forte Biosciences vs. Rezolute | Forte Biosciences vs. Tempest Therapeutics | Forte Biosciences vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |